This was more frequent in fluke-associated CCA which account for 10.4% compared with 2.7% of fluke-negative CCA, resulting in the elevation of ERBB2 gene expression in fluke-associated CCA compared with fluke-negative cases. This evidence concerns the gene ERBB2 and cholangiocarcinoma.